ZIM
TECX

Zacks Investment Management’s Tectonic Therapeutic TECX Stock Holding History

Zacks Investment Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,484
Closed -$252K – 602
2019
Q3 		$252K Buy
+1,484
New +$336K 0.01% 489

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zacks Investment Management's TECX Position: Q4 2019 in Review

Zacks Investment Management sold out of Tectonic Therapeutic (TECX) in Q4 2019, closing a stake of 1,484 shares — an estimated $252K sold.

Zacks Investment Management first reported a position in TECX in Q3 2019 and held it in 1 quarter. The position peaked at $252K in Q3 2019. 89 funds tracked by Wall St. Rank hold TECX as of Q4 2019.

  • Zacks Investment Management reported no remaining Tectonic Therapeutic position as of Q4 2019 after selling out during the quarter.
  • Zacks Investment Management sold 1,484 Tectonic Therapeutic shares in Q4 2019, an estimated $252K.
  • Zacks Investment Management first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 1 quarter.
  • Zacks Investment Management's Tectonic Therapeutic position peaked at $252K in Q3 2019.
  • 89 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2019.

Based on Zacks Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.